Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Shen, Yiguo ^a,b,d   Kapfhamer, David ^a,b   Minnella, Angela M ^a,b   Kim, Ji Eun ^a,b   Won, Seok Joon ^a,b   Chen, Yanting ^a,b,c   Huang, Yong ^a   Low, Ley Hian ^a,b   Massa, Stephen M ^a,b   Swanson, Raymond A ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Adaptive Biotechnologies South San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; COREPRESSOR PROTEIN; CTBP PROTEIN; E1A ASSOCIATED P300 PROTEIN; GLUCOSE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASE; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SYNTHETIC PEPTIDE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ALCOHOL DEHYDROGENASE; C-TERMINAL BINDING PROTEIN; CTBP2 PROTEIN, MOUSE; DNA BINDING PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; NICOTINAMIDE ADENINE DINUCLEOTIDE; P300-CBP-ASSOCIATED FACTOR; PHOSPHOPROTEIN;

BIOENERGETICS; BRAIN; CHEMICAL BINDING; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNE RESPONSE; INNATE BEHAVIOR; METABOLISM; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MICROGLIA; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN ACETYLATION; RAT; ANIMAL; BINDING SITE; ENERGY METABOLISM; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION;

ALCOHOL OXIDOREDUCTASES; ANIMALS; BINDING SITES; CO-REPRESSOR PROTEINS; DIMERIZATION; DNA-BINDING PROTEINS; ENERGY METABOLISM; GLUCOSE; IMMUNITY, INNATE; MACROPHAGES; MICE; MICROGLIA; NAD; NF-KAPPA B; P300-CBP TRANSCRIPTION FACTORS; PHOSPHOPROTEINS; RATS; RAW 264.7 CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 85029867355     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-00707-0     Document Type: Article

References (64)

1. Brown, G. C. & Neher, J. J. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 41, 242-247 (2010).
2. Chen, Y., Won, S. J., Xu, Y. & Swanson, R. A. Targeting microglial activation in stroke therapy: pharmacological tools and gender effects. Curr. Med. Chem. 21, 2146-2155 (2014).
3. An, C. et al. Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog. Neurobiol. 115, 6-24 (2014).
4. Loane, D. J. & Byrnes, K. R. Role of microglia in neurotrauma. Neurotherapeutics 7, 366-377 (2010).
5. Longo, V. D. & Mattson, M. P. Fasting: molecular mechanisms and clinical applications. Cell Metab. 19, 181-192 (2014).
6. Goth, A. Inhibition of anaphylactoid edema in the rat by 2-deoxyglucose. Am. J. Physiol. 197, 1056-1058 (1959).
7. Gasior, M., Rogawski, M. A. & Hartman, A. L. Neuroprotective and diseasemodifying effects of the ketogenic diet. Behav. Pharmacol. 17, 431-439 (2006).
8. Yu, Z. F. & Mattson, M. P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57, 830-839 (1999).
9. Loncarevic-Vasiljkovic, N. et al. Caloric restriction suppresses microglial activation and prevents neuroapoptosis following cortical injury in rats. PLoS ONE 7, e37215 (2012).
10. Tu, Y. F., Lu, P. J., Huang, C. C., Ho, C. J. & Chou, Y. P. Moderate dietary restriction reduces p53-mediated neurovascular damage and microglia activation after hypoxic ischemia in neonatal brain. Stroke 43, 491-498 (2012).
11. Appelberg, K. S., Hovda, D. A. & Prins, M. L. The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. J. Neurotrauma 26, 497-506 (2009).
12. Wang, Q. et al. Pyruvate protects against experimental stroke via an antiinflammatory mechanism. Neurobiol. Dis. 36, 223-231 (2009).
13. Kaur, C., Rathnasamy, G. & Ling, E. A. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J. Neuroimmune Pharmacol. 8, 66-78 (2012).
14. Robbins, N. M. & Swanson, R. A. Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism. Stroke 45, 1881-1886 (2014).
15. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
16. Ghosh, S., George, S., Roy, U., Ramachandran, D. & Kolthur-Seetharam, U. NAD: a master regulator of transcription. Biochim. Biophys. Acta 1799, 681-693 (2010).
17. Hildebrand, J. D. & Soriano, P. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol. Cell Biol. 22, 5296-5307 (2002).
18. Chinnadurai, G. Transcriptional regulation by C-terminal binding proteins. Int. J. Biochem. Cell Biol. 39, 1593-1607 (2007).
19. Kuppuswamy, M. et al. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol. Cell Biol. 28, 269-281 (2008).
20. Kim, J. H., Cho, E. J., Kim, S. T. & Youn, H. D. CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain. Nat. Struct. Mol. Biol. 12, 423-428 (2005).
21. Birts, C. N. et al. A cyclic peptide inhibitor of C-terminal binding protein dimerization links metabolism with mitotic fidelity in breast cancer cells. Chem. Sci. 4, 3046-3057 (2013).
22. Bhambhani, C., Chang, J. L., Akey, D. L. & Cadigan, K. M. The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets. EMBO J. 30, 2031-2043 (2011).
23. Verger, A. et al. Mechanisms directing the nuclear localization of the CtBP family proteins. Mol. Cell Biol. 26, 4882-4894 (2006).
24. Quinlan, K. G. et al. Role of the C-terminal binding protein PXDLS motif binding cleft in protein interactions and transcriptional repression. Mol. Cell Biol. 26, 8202-8213 (2006).
25. Chen, L. F., Mu, Y. & Greene, W. C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21, 6539-6548 (2002).
26. Zhang, Q., Piston, D. W. & Goodman, R. H. Regulation of corepressor function by nuclear NADH. Science 295, 1895-1897 (2002).
27. Garriga-Canut, M. et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 9, 1382-1387 (2006).
28. Yao, J., Chen, S., Mao, Z., Cadenas, E. & Brinton, R. D. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS ONE 6, e21788 (2011).
29. Forstermann, U. & Kleinert, H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Pharmacol. 352, 351-364 (1995).
30. Williamson, D. H., Lund, P. & Krebs, H. A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103, 514-527 (1967).
31. Alano, C. C. et al. Differences among cell types in NAD(+) compartmentalization: A comparison of neurons, astrocytes, and cardiac myocytes. J. Neurosci. Res. 85, 3378-3385 (2007).
32. Karovic, O. et al. Toxic effects of cobalt in primary cultures of mouse astrocytes. Similarities with hypoxia and role of HIF-1alpha. Biochem. Pharmacol. 73, 694-708 (2007).
33. Poole, R. C. & Halestrap, A. P. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264, C761-782 (1993).
34. Reiss, P. D., Zuurendonk, P. F. & Veech, R. L. Measurement of tissue purine, pyrimidine, and other nucleotides by radial compression high-performance liquid chromatography. Anal. Biochem. 140, 162-171 (1984).
35. Ying, W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal 10, 179-206 (2008).
36. Palero, J. A. et al. In vivo monitoring of protein-bound and free NADH during ischemia by nonlinear spectral imaging microscopy. Biomed. Opt. Express 2, 1030-1039 (2011).
37. Nardini, M. et al. CtBP/BARS: a dual-function protein involved in transcription co-repression and Golgi membrane fission. EMBO J. 22, 3122-3130 (2003).
38. Qin, H. et al. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc. Natl Acad. Sci. USA 109, 5004-5009 (2012).
39. Meloni, A. R., Lai, C. H., Yao, T. P. & Nevins, J. R. A mechanism of COOH-terminal binding protein-mediated repression. Mol. Cancer Res. 3, 575-583 (2005).
40. Di, L. J., Fernandez, A. G., De Siervi, A., Longo, D. L. & Gardner, K. Transcriptional regulation of BRCA1 expression by a metabolic switch. Nat. Struct. Mol. Biol. 17, 1406-1413 (2011).
41. Zhang, Q. et al. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc. Natl Acad. Sci. USA 103, 9029-9033 (2006).
42. Fjeld, C. C., Birdsong, W. T. & Goodman, R. H. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc. Natl Acad. Sci. USA 100, 9202-9207 (2003).
43. McGettrick, A. F. & O'Neill, L. A. How metabolism generates signals during innate immunity and inflammation. J. Biol. Chem. 288, 22893-22898 (2013).
44. Feldman, J. L., Dittenhafer-Reed, K. E. & Denu, J. M. Sirtuin catalysis and regulation. J. Biol. Chem. 287, 42419-42427 (2012).
45. Bergman, L. M. et al. Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins. BMC Cell Biol. 7, 35 (2006).
46. Saijo, K., Collier, J. G., Li, A. C., Katzenellenbogen, J. A. & Glass, C. K. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microgliamediated inflammation. Cell 145, 584-595 (2011).
47. Xu, X. et al. EVI1 acts as an inducible negative-feedback regulator of NFkappaB by inhibiting p65 acetylation. J. Immunol. 188, 6371-6380 (2012).
48. Moon, J. S. et al. mTORC1-Induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 12, 102-115 (2015).
49. Wang, B. et al. Glycolysis-dependent histone deacetylase 4 degradation regulates inflammatory cytokine production. Mol. Biol. Cell 25, 3300-3307 (2015).
50. Manigrasso, M. B., Juranek, J., Ramasamy, R. & Schmidt, A. M. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol. Metab. 25, 15-22 (2014).
51. Warburg, O. On respiratory impairment in cancer cells. Science 124, 269-270 (1956).
52. Calle, M. C. & Fernandez, M. L. Inflammation and type 2 diabetes. Diabetes Metab. 38, 183-191 (2012).
53. Horvath, P. et al. Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes. J. Investig. Med. 61, 972-977 (2013).
54. Lowenstein, C. J. et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl Acad. Sci. USA 90, 9730-9734 (1993).
55. Suh, S. W. et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 64, 654-663 (2008).
56. Kauppinen, T. M. et al. Zinc triggers microglial activation. J. Neurosci. 28, 5827-5835 (2008).
57. d'Avila, J. C. et al. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J. Neuroinflammation 9, 31 (2012).
58. del Rio, J. A. & Soriano, E. Regenerating cortical connections in a dish: the entorhino-hippocampal organotypic slice co-culture as tool for pharmacological screening of molecules promoting axon regeneration. Nat. Protoc. 5, 217-226 (2010).
59. Brennan, A. M., Connor, J. A. & Shuttleworth, C. W. NAD(P)H fluorescence transients after synaptic activity in brain slices: predominant role of mitochondrial function. J. Cereb. Blood Flow Metab. 26, 1389-1406 (2006).
60. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1): S96-104 (2002).
61. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).
62. Shen, Y. et al. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Hum. Mol. Genet. 20, 2322-2332 (2011).
63. Saijo, K. et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47-59 (2009).
64. Zschiedrich, I. et al. Coactivator function of RIP140 for NFkappaB/RelAdependent cytokine gene expression. Blood 112, 264-276 (2008).